United States · FDA National Drug Code directory

PROPRINAL

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
50332-0130_accace16-6289-44cb-bbfc-99103d282fa2
Product NDC
50332-0130
Form
CAPSULE, LIQUID FILLED
Composition / generic term
Ibuprofen Capsules 200 mg
Labeler
HART Health
Marketing category
ANDA
Marketing start / end (source format)
20170111
Source listing expiry
20261231

Source-listed ingredients

  • IBUPROFEN — 200 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 300 PACKET in 1 BOX (50332-0130-1) / 2 CAPSULE, LIQUID FILLED in 1 PACKET · 50332-0130-1
  • 20 PACKET in 1 BAG (50332-0130-3) / 2 CAPSULE, LIQUID FILLED in 1 PACKET · 50332-0130-3
  • 40 PACKET in 1 BOX (50332-0130-4) / 2 CAPSULE, LIQUID FILLED in 1 PACKET · 50332-0130-4
  • 100 PACKET in 1 BOX (50332-0130-7) / 2 CAPSULE, LIQUID FILLED in 1 PACKET · 50332-0130-7
  • 200 PACKET in 1 BOX (50332-0130-8) / 2 CAPSULE, LIQUID FILLED in 1 PACKET · 50332-0130-8

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →